A simple and reliable protocol for long-term culture of murine bone marrow stromal (mesenchymal) stem cells that retained their in vitro and in vivo stemness in long-term culture by Abdallah, Basem M. et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
A simple and reliable protocol for long-term culture of murine bone marrow stromal
(mesenchymal) stem cells that retained their in vitro and in vivo stemness in long-term
culture
Abdallah, Basem M.; Alzahrani, Abdullah M.; Abdel-Moneim, Ashraf M.; Ditzel, Nicholas;
Kassem, Moustapha
Published in:
Biological Procedures Online
DOI:
10.1186/s12575-019-0091-3
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Abdallah, B. M., Alzahrani, A. M., Abdel-Moneim, A. M., Ditzel, N., & Kassem, M. (2019). A simple and reliable
protocol for long-term culture of murine bone marrow stromal (mesenchymal) stem cells that retained their in
vitro and in vivo stemness in long-term culture. Biological Procedures Online, 21(1), [3].
https://doi.org/10.1186/s12575-019-0091-3
Download date: 03. Feb. 2020
RESEARCH Open Access
A simple and reliable protocol for long-
term culture of murine bone marrow
stromal (mesenchymal) stem cells that
retained their in vitro and in vivo stemness
in long-term culture
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Abstract
Background: Bone marrow derived stromal stem cells (BMSCs) are a clonogenic cell population that is characterized by
self-renewal capacity and differentiation potential into osteoblasts, and other mesenchymal cell types. Mouse BMSCs
(mBMSCs) are difficult to be cultured and propagated in vitro due to their replicative senescent phenotype, heterogeneity
and high contamination with plastic adherent hematopoietic progenitors (HPCs). In this study, we described long-term
culture of homogenous population of mBMSCs using simple and highly reproducible approach based on frequent
subculturing (FS) at fixed split ratio in the presence of basic fibroblast growth factor (bFGF).
Results: Cultured mBMSCs using this protocol (mBMSCs-FS) showed long-term survival in culture > 70 population
doubling (PD) and retained their characteristic surface markers and differentiation capacity into osteoblast and adipocyte
lineages. When compared to the clonal bone marrow-derived cell line ST2, mBMSCs-FS displayed more enhanced
osteoblast differentiation potential and responsiveness to osteogenic factors including BMPs, IGF-1, PDGF, TGFβ1,3, FGF,
cAMP, Wnt3a and VEGF. In addition, unlike ST2 cells, mBMSCs-FS maintained capacity to form ectopic bone and bone
marrow stroma upon in vivo transplantation in immune-compromising mice, even at high PD levels. Interestingly, by
applying the same FS + bFGF protocol, we succeeded to obtain long-term cultures of primary neonatal calvarial
osteoprogenitor cells (OBs) that were cultured for more than 70 PD and maintained in vitro and in vivo osteoblast
differentiation capacities.
Conclusions: Our data provide a simple and reliable protocol for generating long-term cultures of mBMSCs and OBs with
retained high in vitro and in vivo osteoblast differentiation capacities for use in pre-clinical and molecular mechanism
studies.
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Background
Adult stromal stem cells isolated from bone marrow (also
known as skeletal stem cells, BMSCs) are a group of low
frequent cells that have high capacity of differentiation
into various mesoderm-cell types including osteoblast,
adipocyte and chondrocyte cell lineages. BMSCs have
been successfully used in regenerative medicine and
tissue engineering, due to their differentiation cap-
acity, immune-modulatory functions and paracrine
effect [1, 2].
Isolation and culturing of mouse-derived BMSCs
(mBMSCs) are crucial steps for investigating the mecha-
nisms controlling the molecular cell determination of
osteogenesis using bone-related transgenic mouse
models. However, factors including the low frequencies
of BMSCs in bone marrow, contamination with plastic
adherent hematopoietic progenitors (HPCs) and replica-
tive senescence phenotype hampered the culturing of
large amount of mBMSCs in pure yield that can be used
efficiently in different molecular and cellular studies [3, 4].
Several techniques have been used to isolate BMSCs
from mouse bone marrow, including using different
plating density [5], negative and positive selection based
on specific surface marker expression [6–8], frequent
medium change in primary culture [9], passage-dependent
reseeding following trypsinization [10], centrifugation on a
Percoll gradient [11] and cell sorting for CD29 (Itgb1) and
CD54 (Icam1) [12]. However, these methods are not
simple, need special requirements and do not always re-
sult in long-term cultures of BMSCs.
On the other hand, several immortalized cell lines
with the characteristics phenotype of mBMSCs in-
cluding in vitro multi-lineage differentiation potential
have been established from mouse bone marrow.
These clonal cell lines include for example, ST2 cells
[13], mesenchymal progenitor cell line C3H10T1/2
[14] and TBR31–2 cell [15]. However, immortalized
status of these cell lines significantly affected the
maintenance of BMSCs physiological function in vivo.
For example, the ST2 cell line has been extensively
used as a model of (mBMSCs) in vitro, despite lack-
ing the capacity for in vivo ectopic bone formation,
except in the presence of BMP2 upon transplantation
[16]. Thus, there is a need for developing simple and
fast protocol for culturing and expanding large num-
ber of mBMSCs in long term with intact in vitro and
in vivo multi-lineage differentiation.
In this study, we described simple and reprodu-
cible protocol for long-term culture of BMSCs/osteo-
progenitors based on FS in the presence of bFGF.
Using this protocol, we obtained long-term culture
of mBMSCs and mOBs with retained high osteogenic
differentiation capacity in vitro and in vivo at high
passage number.
Results
Simple protocol for culturing and expanding murine
BMSCs in long term
We aimed to develop a simple, fast and highly reprodu-
cible protocol for culturing and expanding large number
of mBMSCs for mechanistic and preclinical translational
studies. We culture the primary mBMSCs using the
traditional method of plastic adherence after avoiding
the fast-adhered HPCs [17]. Cells were then, frequently
sub-cultured at split ratio 1:2, when reached 90% conflu-
ence in 5 ng/mL bFGF for long term (Fig. 1a). We have
applied this protocol to culture and expand mBMSCs
derived from 3 independent mice. As shown in Fig. 1b,
long-term growth curves of the three different cultures
of mBMSCs (mBMSCs-FS1 to 3) showed long-term
culture for more than 80 PDL during a period of ap-
proximately 150 days without growth arrest. On the
other hand, culture of primary mBMSCs (pBMSCs)
using traditional method without bFGF experienced sen-
escent association growth arrest after 6 PDL (Fig. 1b).
BMSCs-FS at p25 (70 PD) displayed homogenous popu-
lation with spindle shape like structure as compared to
the heterogeneous, large and flat shaped primary cell
population of pBMSCs (p5) (cultured without FGF) as
assessed by phase contrast microscopic analysis (Fig. 1c).
Furthermore, BMSCs-FS at p25 expressed the character-
istic surface markers of mouse mesenchymal stem cells
including Sca-1, CD140a, CD29, CD44, and CD105 and
did not express hematopoietic marker CD45 as mea-
sured by FACS analysis (Fig. 1d).
Increased in vitro osteogenic potential of BMSCs-FS at
high PDL
To study whether BMSCs-FS can maintain their multili-
neage differentiation capacities at high PDL, we com-
pared the osteogenic and adipogenic differentiation of
BMSCs-FS (at PDL 70, p25) with the commercially avail-
able immortalized ST2 cell line. As shown in Fig. 2a,
both cell lines could differentiate efficiently into mature
adipocytes as assessed by increased Oil red O staining
for the accumulation of lipid droplets and significant
up-regulation of early (Pparγ2 and C/ebpα) and late
(aP2, Apm1) adipogenic gene expression markers (Fig. 2
a & b). However, the differentiation capacity of
BMSCs-FS (p25) into adipocytes was less than that of
ST2 cell line as shown by reduced the accumulation of
fatty acids and expression of adipocytic markers (Fig. 2 a
& b). In contrast, BMSCs-FS (p25) showed high osteo-
genic differentiation potential compared to ST2 cell line,
as evaluated by significant increased levels of ALP activ-
ity and formation of matrix mineralization (Fig. 3a & b).
Quantitative mRNA expression levels of early (Runx2,
Msx2, Dlx5, and Alp) and late osteoblastic markers (Ocn
and Opn) were significantly up-regulated in BMSCs-FS
Abdallah et al. Biological Procedures Online            (2019) 21:3 Page 2 of 11
compared to ST2 cells (Fig. 3c). In consistent, qPCR-
based osteogenic gene array analysis revealed the upreg-
ulation of 67.5% (≥2 fold, p < 0.05) of the differentially
expressed osteoblastic genes in BMSCs-FS during their
osteogenesis compared to ST2 cells (Fig. 3d, Table 1 and
Additional file 1: Table S2). The up-regulated genes by
BMSCs-FS included osteogenic growth factors, osteo-
blast differentiation and BMP signaling related-genes
that represent 19.3, 22.5, and 19.3% respectively of total
upregulated genes (Fig. 3d).
We further compared the osteogenic response of
BMSCs-FS (p25) and ST2 toward a variety of known
osteogenic signaling molecules. As shown in Fig. 4a & b,
BMSCs-FS treated with BMP-7, Insulin, IGF-1, cAMP,
PDGF-BB, VEGF and FGF at both 10 and 100 ng/mL
(and 1 and 10 μg/mL for insulin) showed significantly in-
creased ALP activity compared to ST2 cells (Fig. 4a &
b). In addition, BMSCs-FS showed significant increased
ALP activity in response to both BMP-2 and BMP-4 at
10 ng/mL as compared to ST2 cells (Fig. 4a). On the
other hand, the effects of both TGF-β1 and TGF-β3 at
10 and 100 ng/mL and both BMP-2 and BMP-4 at 100
ng/mL on ALP activity were comparable between
BMSCs-FS and ST2 cells (Fig. 4a). ST2 cells showed
significant high ALP activity as compared to BMSCs-FS
in response to Wnt3a (Fig. 4b).
BMSCs-FS retains their stemness in vivo at high PDL
compared to ST2 cell line
The capacity of BMSCs to form ectopic bone and bone
marrow stroma in vivo, is a standard assay for verifying
the stemness of skeletal stem cells [18]. Thus, we mixed
ST2 cells and BMSCs-FS (three different cell lines at
PDL ≥ 70, p25); with HA/TCP powder and implanted
them subcutaneously in immune-deficient mice for two
months. As shown in Fig. 5a, histological analysis of
A B
C
D
Fig. 1 Long term culturing of primary mBMSCs using a combination of FS and bFGF. a Workflow of simple and reliable protocol used to culture
and expand primary mBMSCs in long term. b Long term growth curves of primary isolated mBMSCs cultured by traditional method and three
independent BMSCs-FS cell lines cultured by our new protocol in the presence of bFGF. c Phase contrast representative images (20x) of pBMSCs
(p5) and three independent BMSCs-FS cell lines (at 70 PDL, p25). d FACS analysis of the expression of MSC surface markers by BMSCs-FS, p25.
Values are mean ± SD of three independent experiments
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BMSCs-FS implants revealed the formation of hetero-
topic bone and bone marrow stroma including adipo-
cytes. On the other hand, ST2 cells were unable to
differentiate into bone in vivo (Fig. 5).
Long-term culture of murine osteoprogenitors using FS
and bFGF protocol
To examine whether, the above BMSCs culture protocol
can be applied for establishing long-term culture of
other bone related cells, we cultured the primary murine
neonatal OBs by using FS protocol in the presence of
bFGF (5 ng/mL). As shown in Fig. 6a, OBs-FS displayed
long term culture with more than 70 PDL, while OBs
cultured with traditional protocol (see M&M) experi-
enced replicative senescent after 10 PDL. In addition,
OBs-FS at PDL 50 (p30) showed homogenous cell popu-
lation with cuboidal shape like structure as compared
with primary OBs at PDL 10 (p7) (Fig. 6b). We further
examined in vitro and in vivo osteoblast differentiation
of OBs-FS. At PDL 50 (p30), OBs-FS retained their in
vitro differentiation potential into osteoblast as assessed
by increased ALP activity and Alizarin red staining for
matrix mineralization (Fig. 6c). In addition, OBs-FS at
PDL 50 (p30) showed to form significant high percent-
age of ectopic bone in vivo upon implantation with HA/
TCP powder in immune-deficient mice as compared
with pOBs (Fig. 6d).
Discussion
In this report, we described a fast and reliable protocol
for long term culturing of primary BMSCs, that com-
bines frequent-subculture and bFGF. This method af-
fords high yield of BMSCs, while maintaining their in
vitro and in vivo stemness. In addition, our protocol
A
B
Fig. 2 Long term cultured BMSCs-FS differentiates efficiently into adipocytic cell lineage. a Adipocyte differentiation of BMSCs-FS (p25) as
compared with ST2 cell line. Cells were induced with adipogenic cocktail (M&M) and accumulation of fat droplets during the time course of
differentiation were measured by quantitative Oil Red O staining. Representative images of Oil Red O staining are shown at each time point
during adipogenesis of BMSCs-FS and ST2 cells. b qPCR analysis of the adipogenic markers expression in BMSCs-FS and ST2 cells after 12 days of
adipogenic induction. Data were represented as fold change over control non-induced. Values are mean ± SD of three independent experiments,
(*p < 0.05, compared to ST2 cells at the same time points). Columns of the same group with different letters at each time point indicate
significant differences according to Duncan’s multiple range tests at p < 0.05
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proved to be applicable for culturing primary murine
OBs with long life span and high in vitro and in vivo
osteoblast differentiation potentials. Our simple and fast
protocol will allow to culture large numbers of BMSCs/
OBs from transgenic mouse models, for mechanistic
studies and translational research applications in the
bone field.
We and the others have demonstrated BMSCs, as a
group of heterogeneous subpopulations that differs in
their in vitro and in vivo proliferation and differentiation
capacities [19–21]. However, several protocols that
succeeded for generating mBMSCs with long life span
were mainly dependent on selecting specific subpopu-
lations with high proliferation/differentiation potential
[5, 17, 22]. Such selection for particular BMSCs sub-
populations might influence the use of BMSCs in transla-
tional research aspects, and for identifying osteogenic
mechanism in particular transgenic mouse model. In
contrast to other protocols, our FS method, at fixed split
ratio provides long-term culture of BMSCs with whole
population by avoiding the utilization of any depletion
step to remove senescent cells or to select for any particu-
lar subpopulation.
Our data demonstrated that bFGF supplementation
was very efficient to promote proliferation, extend life
span of BMSCs and maintain differentiation of BMSCs.
In consistent, bFGF supplementation has been used as a
mitogenic factor to promote self-renewing and inhibit
cellular senescence of stem cells [3, 23, 24]. For example,
bFGF was used in a combination with bone-marrow-
conditioned medium [25], and hypoxia [26] to expand
BMSCs in long term culture and to maintain their stem-
ness. The action of FGF to inhibit cellular senescence
and to promote proliferation of mouse BMSC was found
to be mediated through the suppression of PI3K/
AKT-MDM2 pathway [27] and activation of ERK
A
C D
B
Fig. 3 Increased osteogenic differentiation capacity in BMSCs-FS as compared with ST2 cells. a Osteoblast differentiation of BMSCs-FS (p25) as
compared with ST2 cell line. Cells were induced with osteogenic cocktail and osteogenesis was measured by quantitative alkaline phosphatase
activity (ALP) and (b) Alizarin red staining. ALP and Alizarin red measurements were normalized to the cell number. ALP and Alizarin red staining
images are shown. c qPCR analysis of the osteogenic markers mRNA expression after 12 days of induction in BMSCs-FS compared to ST2 cell line.
Each target gene was normalized to reference genes and presented as fold change over control induced. Date were represented as fold change
over control non-induced. d Up-regulated osteogenic genes in BMSCs-FS versus ST2 cells after 6 days of osteogenic induction. Gene
expression was measured by qPCR using osteogenic RT2 profiler array as described in M&M. Values are mean ± SD of three independent
experiments, (*p < 0.05, **p < 0.005, compared to ST2 cells at the same time points). Columns of the same group with different letters at
each time point indicate significant differences according to Duncan’s multiple range tests at p < 0.05
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pathway respectively [26, 28]. In this context, our proto-
col showed several advantages over others that have
used bFGF supplementation, including; 1) It does not
need any special requirements like hypoxic condition or
selection for specific sub-populations with unique grow-
ing potential [26–28]; 2) it results in high yields of
immortalized BMSCs with retained in vitro and in vivo
stemness. 3) it is fast and straightforward protocol, that
proved to be applicable for culturing other bone-related
cell types including osteoprogenitors.
Furthermore, our finding that bFGF maintained the in
vivo multipotency differentiation of BMSCs to form ec-
topic bone and bone marrow stroma, suggesting a role
for bFGF in enhancing the regenerative repair of
BMSCs. In support to this notion, bFGF treatment of
hyaluronic acid-based polymer scaffold in combination
with BMSCs was reported to promote the healing of
large segmental bone defects in a rat model [29].
Furthermore, bFGF was shown to enhance the thera-
peutic efficacy of transplanted BMSCs for myocardial
infarction in pre-clinical animal model [30, 31]. Thus,
our protocol could provide high yield of BMSCs with
enhanced potential for bone repair. However, further in
vivo studies are needed to investigate the therapeutic po-
tential of BMSCs for bone repair in animal model of
bone defect.
Several studies have demonstrated long-term culture
of plastic-adherent mouse BMSCs [4, 25, 32]. On the
other hand, some reports demonstrated that mouse
BMSCs might exhibit chromosomal instability and in
vivo tumorigenicity, in a mechanism mediated by p53
mutation [33–36]. In this context, we used in vivo
ectopic bone formation assay as a gold standard assay
for testing the stemness of mBMSCs in vivo as well as to
observe any possibility for in vivo tumor formation upon
cell transplantation. In contrast, most culture protocols
for generating immortalized BMSCs did not examine the
in vivo bone regenerative capacity of cultured mBMSCs
[4, 17, 25, 32, 37, 38]. Interestingly, our in vivo data
demonstrated that both BMSCs-FS and OBs-FS cell lines
have the potential to form heterotropic bone in vivo
upon transplantation with HA/TCP with no sign of
tumor formation. Despite these data is not fully ad-
equate to exclude the possibility of any genetic instability
led to transformation in BMSCs or OBs-FS, our in vivo
data were significant enough to demonstrate that our
straightforward and fast protocol could provide robust
BMSCs safe to be used in pre-clinical applications
including cell therapy and bone-tissue engineering.
Conclusion
In summary, our data provide a simple protocol for long
term culturing of mouse BMSCs and OBs based on
using FS in the presence of low dose of bFGF. This
Table 1 Upregulated osteoblastic genes by BMSCs-FS (p25)
versus ST2 cells
Gene name Gene symbol Fold
Ossification and matrix molecules
Alkaline phosphatase, liver/bone/kidney Alpl 7.9
Bone gamma carboxyglutamate protein Bglap 2.1
Collagen, type I, alpha 1 Col1a1 7.5
Collagen, type I, alpha 2 Col1a2 4.2
Fibroblast growth factor receptor 1 Fgfr1 4.4
Fibroblast growth factor receptor 2 Fgfr2 2.3
Insulin-like growth factor I receptor Igf1r 2.2
BMP signaling pathway
Bone morphogenetic protein 2 Bmp2 74
Bone morphogenetic protein 3 Bmp3 25.3
Bone morphogenetic protein 5 Bmp5 2
Bone morphogenetic protein 6 Bmp6 17.7
Bone morphogenetic protein receptor, type 1B Bmpr1b 3.8
Bone morphogenetic protein 4 Bmp4 2
Extracellular Matrix (ECM) Molecules
Biglycan Bgn 2
Collagen, type II, alpha 1 Col2a1 7.5
Collagen, type III, alpha 1 Col3a1 2.2
Collagen, type XIV, alpha 1 Col14a1 2.2
Collagen, type V, alpha 1 Col5a1 2.6
Integrin alpha 2 Itga2 10
Integrin alpha 2b Itga2b 1.5
Matrix metallopeptidase 2 Mmp2 17
Matrix metallopeptidase 8 Mmp8 12
Matrix metallopeptidase 9 Mmp9 23.7
Osteogenic growth factors
Colony stimulating factor 1 (macrophage) Csf1 3
Fibroblast growth factor 1 Fgf1 2.5
Fibroblast growth factor 2 Fgf2 2.7
Growth differentiation factor 10 Gdf10 3.7
Insulin-like growth factor 1 Igf1 2
Platelet derived growth factor, alpha Pdgfa 3.2
Osteogenic transcription factors
Runt related transcription factor 2 Runx2 4.5
Sp7 transcription factor 7 Sp7 6.7
Cells were induced into osteoblast differentiation as described in the M&M.
Mouse osteogenesis RT2 Profiler™ PCR array with 84 osteogenic genes was
performed using the SYBR® Green quantitative PCR method. Each target gene
was normalized to a group of reference genes as described by manufacture
instruction’s. Up-regulated genes (≥ 2 fold) by BMSCs-FS are represented as
fold change over ST2 cells
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protocol proved to be simple and highly reproducible to
yield homogenous populations of BMSCs and OBs with
robust differentiation capacity into osteogenic cell
lineage in vitro and in vivo at high PD levels. Unlike
other reported protocols, the cultured BMSCs and OBs
using our protocol showed no sign of tumorigenicity
upon in vivo transplantation in mice, suggesting their
safe use in translational research applications.
Methods
Isolation and cultivation of BMSCs
The ethical approval for ex-vivo and in vivo animal pro-
cedures were approved by the Danish Animal Ethical
committee. Primary mouse BMSCs (mBMSCs) were iso-
lated from the bone marrow of wild-type 8-weeks-old
C57BL/6J mice as described previously [17]. In brief, the
femur and tibia were dissected from mice and bone mar-
row was flushed out with complete isolation media
(CIM), which consists of RPMI-1640 (Roswell Park
Memorial Institute), supplemented with 10% fetal bovine
serum (FBS; GIBCO), 100 U/mL penicillin (Gibco,
Thermo Fisher Scientific, Darmstadt, Germany) and
100 μg/mL streptomycin (GIBCO). Cells were washed
with PBS, filtered (through 70 μM nylon mesh filter)
and cultured in 40 mL CIM in a 175-cm2 flask in 5%
CO2 incubator at 37 °C. Non-adherent cells were
removed after 24 h, passage 0 (p0) and sub-cultured
in 10 ml of fresh CIM in 60-cm2 flask (p1). Cells
were passaged every 1 week using 0.25% trypsin/1 mM
EDTA.
For our frequent subculture (FS) protocol, BMSCs
(p1) at 90% confluence were sub-cultured at split ratio
1:2 in complete culture medium (CCM) consist of Iscove
modified Dulbecco medium (IMDM; GIBCO) supple-
mented with 10% FBS, bFGF (5 ng/mL), 100 U/ml
penicillin, 100 μg/ml streptomycin (GIBCO), and 12 μM
A
B
Fig. 4 Increased the response of BMSCs-FS to osteogenic signaling factors. a, b Response of BMSCs-FS (p25) Vs ST2 cells to different osteogenic
growth factors as measured by quantitative ALP activity. Cells were either cultured without osteogenic induction media (C, control), or induced to
osteogenic lineage in the absence (I, induced) or the presence of 10 and 100 ng/mL of different osteogenic growth factors for 6 days. Representative
images of ALP staining are shown. ALP measurements were normalized to cell number and represented as fold change over control non-induced
cells. Data are mean ± SD of three independent experiments. (*p < 0.05, **p < 0.005, compared to ST2 cells with the same condition). Columns of the
same group with different letters at each growth factor indicate significant differences according to Duncan’s multiple range tests at p < 0.05
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l-glutamine (GIBCO). BMSCs were continued to be
sub-cultured always (at 90% cell confluence) at split ratio
1:2 in CCM supplemented with bFGF (5 ng/mL) for
several passages.
Mice OBs were isolated from the calvarias of neo-
natal pups (3 to 4 days old) as described [39]. Briefly,
calvarias were dissected and subjected to sequential
collagenase II digestion at 37 °C. Cells (p0) were
cultured in complete osteoprogenitor medium (COM)
consists of Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) with 20% fetal bovine serum (FBS)
and 100 mg/mL of streptomycin (Gibco) and 100 U/
mL of penicillin (Gibco).
For our FS protocol, OBs (p1) at 90% cell confluence
were sub-cultured in COM supplemented with bFGF (5
ng/mL) at split ratio 1:2 in COM supplemented with
bFGF (5 ng/mL). OBs were continued to be sub-cultured
(when reached 90% cell confluence) at split ratio 1:2 in
the same medium for long term.
Mouse stromal cell line ST2 was obtained from Leib-
niz Institute DSMZ-German Collection of Microorgan-
isms and Cell Cultures (ACC 333, Braunschweig,
Germany). Cells were cultured in DMEM supplemented
with 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin (P/S) (Gibco Invitrogen, USA).
Osteoblast differentiation
Cells were cultured at 15,000 cells/cm2 in basal culture
medium. At 70% cell confluence, cultured media were
changed to osteogenic induction medium (OIM) consists
of: α-minimum essential medium (α-MEM; Gibco) con-
taining 10% FBS, 100 U/mL of penicillin, 100 mg/mL of
streptomycin, 50 μg/mL of vitamin C (Sigma-Aldrich),
10 nM dexamethasone and 10 mM β-glycerol-phosphate
(Sigma-Aldrich). The media were changed every 2–3
days during the culture.
Adipocyte differentiation
Cells were cultured at 15,000 cells/cm2 in basal culture
medium. At 100% cell confluence, cultured media were
replaced by adipogenic induction medium (AIM) con-
sists of: DMEM supplemented with 9% horse serum,
250 nM dexamethasone, 450 μM 1-methyl-3-isobutyl-
xanthine (IBMX), 1 μM rosiglitazone (BRL 49653, Cay-
man Chemical) and 5 μg/mL insulin (Sigma-Aldrich).
The media were changed every 2–3 days during the time
course of adipocyte differentiation.
Alkaline phosphatase (ALP) activity
ALP activity was determined following the manual in-
structions of ALP assay kit (Abcam plc, Cambridge,
Fig. 5 Maintained in vivo stemness of BMSCs-FS at high PDL. In vivo ectopic bone formation by implanted BMSCs-FS (70 PDL, p25) and ST2 cells. Cells
were mixed with HA/TCP powder and implanted subcutaneously in immune-deficient mice for 2months (n= 6 implants for each cell line). Histological
sections of implants were stained with H&E. Representative images of H&E sections show the in vivo capacity of 3 independent BMSCs-FS to form in vivo
ectopic bone and bone marrow stroma containing adipocytes and fibroblasts. B = Bone, A = Adipocyte, HA = Hydroxyapatite. Scale bars indicate 100 μm
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UK). The color of the reaction was measured at 405 nm.
The number of viable cells was determined using the
Cell Titer-Blue cell viability assay according to the man-
ufacturer’s instructions (Promega, USA) at OD 579. ALP
activity was represented as fold change over control
non-induced cells after normalization to the number of
viable cells [40].
Alizarin red staining for mineralized matrix
Cells were induced to osteoblast differentiation for 12
days. Cells were fixed with 70% ice-cold ethanol for 1 h
at − 20 °C, and stained with 40 mM Alizarin red S (AR-S;
Sigma-Aldrich), pH 4.2 for 10 min at room temperature.
Alizarin red stain was eluted using 10% (w/v) cetylpyridi-
nium chloride solution (Sigma-Aldrich) with shaking for
20 min and the absorbance of the eluted dye was
measured at 570 nm.
Oil Red O staining and quantification
Cells were induced to adipocyte differentiation and then
fixed in 4% paraformaldehyde for 10 min at room
temperature. Cells were stained with Oil Red O (0.5 g in
60% isopropanol) (Sigma-Aldrich) for 1 h at room
temperature to stain the fat droplets. Lipids were quanti-
fied by elution of Oil Red O in isopropanol for 10 min at
room temperature. The absorbance of the extracted dye
was detected at 490 nm. Oil Red O measurements were
normalized to cell umber (measured by number of viable
cells) and then represented as fold change over control
non-induced cells.
RNA extraction and real-time PCR analysis
Total RNA was extracted from cells using single-step
method of TRIzol (Thermo Fisher Scientific) followed by
phenol-chloroform extraction procedure. cDNA was
synthesized from 1 μg of total RNA using revertAid H
A B
D
C
Fig. 6 Long term culturing of primary neonatal calvarial osteoblasts (OBs) using a combination of frequent subculture and bFGF. a Long term
growth curves of primary isolated OBs cultured by traditional method and two independent OBs-FS cell lines cultured by our new protocol in the
presence of bFGF. b Phase contrast representative images (20x) of OBs (p5) and two independent OBs-FS cell lines (at 50 PDL, p30). c Osteoblast
differentiation of OBs-FS, p30 measured by quantitative ALP activity at different time points during differentiation course of 15 days. Representative
images of ALP staining are shown. d In vivo ectopic bone formation by mOBs versus 2 independent OBs-FS cell lines (at 50 PDL, p30). Cells were
mixed with HA/TCP powder and implanted subcutaneously in immune-deficient mice for 2months (n = 6 implants for each cell line). Images of H&E
sections of implants show the formation of ectopic bone by implanted cells. Bone histomorphometric analysis of the percentage of total bone area
per total area of the implants. Data are mean ± SD of three independent experiments, (*p < 0.05, **p < 0.005, compared to mBOs control). For panel c,
columns with different letters at each time point indicate significant differences according to Duncan’s multiple range tests at p < 0.05
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minus first strand cDNA synthesis kit (Fermentas).
Quantitative real time PCR was performed with Applied
Biosystems 7500 Real-Time system using Fast SYBR®
Green Master Mix (Applied Biosystems, California,
USA) with specific primers (Additional file 1: Table S1).
The expression of each target gene was normalized to
β-Actin and Hprt mRNA expression as reference genes,
using a comparative CT method [(1/ (2delta-CT) for-
mula, where delta-CT is the difference between
CT-target and CT-reference] with Microsoft Excel 2007®
as described [41].
PCR array analysis
Total RNA was extracted from mBMSCs and mBMSCs-
FS that induced to osteoblast differentiation for 6 days.
Osteogenic RT2 Profiler™ PCR array, containing 84
osteoblast-related genes (Qiagen Nordic, Denmark), was
performed for each cDNA sample in triplicates using
SYBR® Green quantitative PCR method on Applied
Biosystems 7500 real-time PCR system. Data were ana-
lyzed after normalization to reference genes according to
the manufacturer’s instructions.
Fluorescence activated cell sorting (FACS)
CD surface markers were profiled by incubating the cells
in FACS buffer containing pre-conjugated antibodies (see
Additional file 1: Table S2) for 20min on ice. Cells were
washed twice with FACS buffer and the cell acquisition
was performed with flow cytometer BD FACS LSRII (BD
Biosciences, Albertslund, Denmark). The data were ana-
lyzed using Kaluza®1.2 software (Beckman Coulter Inc.).
In vivo ectopic bone formation assay
Cells were cultured in CIM medium and 5 × 105 cells,
mixed with 40mg hydroxyapatite/ tricalcium phosphate
(HA/TCP) ceramic powder (Zimmer Scandinavia Albert-
slund, Denmark) and implanted subcutaneously in
2-month-old NOD/MrkBomTac-Prkdcscid female mice
(Taconic, Ry, Denmark) (n = 6 implants/cell line). Im-
plants demineralized in EDTA solution ((25% W/V), pH =
7.1), paraffin embedded, sectioned, and stained by eosin/
hematoxylin. The percentage of total bone area per total
implant area was quantified as described previously [18].
Statistical analysis
All values are expressed as mean ± SD (standard devi-
ation) of at least three independent experiments. Stu-
dent’s t-test was used for comparison between two
groups. Differences were considered statistically signifi-
cant at *P < 0.05, and **P < 0.005. In some cases, the data
were also statistically analyzed using One-way analysis of
variance (ANOVA) and differences among the means
were determined for significance at P ≤ 0.05 using Dun-
can’s multiple range test (by SPSS, 16.1 Chicago, USA).
Additional file
Additional file 1: Table S1. List of primers used for qRT-PCR. Table S2.
Full osteogenic gene expression list (total 84 genes) by BMSCs-FS (p25)
versus ST2 cells during osteoblast differentiation including all significant/
non-significant pathways. (DOCX 20 kb)
Abbreviations
AIM: Adipogenic induction medium; ALP: Alkaline phosphatase;
aP2: adipocyte protein 2; Apm1: Adiponectin; AR-S: Alizarin red S; bFGF: Basic
fibroblast growth factor; BMPs: Bone morphogenetic proteins; BMSCs: Bone
marrow derived stromal stem cells; C/ebpα: Ccaat-enhancer-binding protein
alfa; cAMP: Cyclic adenosine monophosphate; CCM: Complete culture
medium; Dlx5: Distal-less homeobox 5; FS: Frequent subculture;
HPCs: Hematopoietic progenitors; IBMX: Isobutylxanthine; IGF-1: Insulin
growth factor 1; IMDM: Iscove modified Dulbecco medium; Msx2: Msh
homeobox 2; OBs: Primary neonatal calvarial osteoprogenitor cells;
Ocn: Osteocalcin; Opn: Osteopontein; P: Passage; PD: Population doubling;
PDGF: Platelet-derived growth factor; Pparγ2: Peroxisome proliferator-
activated receptor gamma2; RPMI-1640: Roswell Park Memorial Institute;
Runx2: Runt-related transcription factor 2; SD: Standard deviation;
TGFβ: Transforming growth factor beta; VEGF: Vascular endothelial growth
factor; Wnt3a: Wnt family protein
Acknowledgments
The Authors acknowledge the Deanship of Scientific Research at King Faisal
University, Saudi Arabia for the financial support (under Grant # 17122008).
Funding
This work was funded by the Deanship of Scientific Research at King Faisal
University, Saudi Arabia, Grant # (17122008). The study was supported by
grants to MK from the NovoNordisk foundation (NNF15OC0016284) and the
Lundbeck foundation (R266–2017-4250).
Availability of data and materials
Datasets and materials are available by the corresponding author.
Authors’ contributions
BMA conceived the project, designed the study, performed experiments,
analyzed data and wrote the manuscript. AZ and AMA performed some
experiments and edited the manuscript. ND performed in vivo experiments;
MK designed the study and edited the manuscript. All authors read and
approved the final manuscript.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Biological Sciences Department, College of Science, King Faisal University,
Hofuf, Al-Ahsa 31982, Saudi Arabia. 2Endocrine Research (KMEB), Department
of Endocrinology, Odense University Hospital and University of Southern
Denmark, Odense, Denmark. 3Department of Zoology, Faculty of Science,
Alexandria University, Alexandria, Egypt. 4Department of Cellular and
Molecular Medicine, DanStem (Danish Stem Cell Center), Panum Institute,
University of Copenhagen, Copenhagen, Denmark. 5Stem Cell Unit,
Department of Anatomy, Faculty of Medicine, King Saud University, Riyadh,
Saudi Arabia.
Abdallah et al. Biological Procedures Online            (2019) 21:3 Page 10 of 11
Received: 18 October 2018 Accepted: 23 January 2019
References
1. Abdallah BM, Jafari A, Zaher W, Qiu W, Kassem M. Skeletal (stromal) stem
cells: an update on intracellular signaling pathways controlling osteoblast
differentiation. Bone. 2015;70:28–36.
2. Bianco P, Robey PG. Skeletal stem cells. Development. 2015;142(6):1023–7.
3. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG.
Characterization of mesenchymal stem cells isolated from murine bone
marrow by negative selection. J Cell Biochem. 2003;89(6):1235–49.
4. Tropel P, Noël D, Platet N, Legrand P, Benabid A-L, Berger F. Isolation and
characterisation of mesenchymal stem cells from adult mouse bone
marrow. Exp Cell Res. 2004;295(2):395–406.
5. Phinney DG, Kopen G, Isaacson RL, Prockop DJ. Plastic adherent stromal
cells from the bone marrow of commonly used strains of inbred mice:
variations in yield, growth, and differentiation. J Cell Biochem. 1999;72(4):
570–85.
6. Houlihan DD, Mabuchi Y, Morikawa S, Niibe K, Araki D, Suzuki S, Okano H,
Matsuzaki Y. Isolation of mouse mesenchymal stem cells on the basis of
expression of Sca-1 and PDGFR-α. Nat Protoc. 2012;7:2103.
7. Mahara A, Yamaoka T. Antibody-immobilized column for quick cell
separation based on cell rolling. Biotechnol Prog. 2010;26(2):441–7.
8. Xu S, De Becker A, Van Camp B, Vanderkerken K, Van Riet I. An improved
harvest and in vitro expansion protocol for murine bone marrow-derived
mesenchymal stem cells. J Biomed Biotechnol. 2010;2010:105940.
9. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal
stem cells from mouse bone marrow. Nat Protoc. 2009;4:102.
10. Sreejit P, Dilip KB, Verma RS. Generation of mesenchymal stem cell lines
from murine bone marrow. Cell Tissue Res. 2012;350(1):55–68.
11. Rosca AM, Burlacu A. Isolation of a mouse bone marrow population
enriched in stem and progenitor cells by centrifugation on a Percoll
gradient. Biotechnol Appl Biochem. 2010;55(4):199–208.
12. Suto EG, Mabuchi Y, Suzuki N, Suzuki K, Ogata Y, Taguchi M, Muneta T,
Sekiya I, Akazawa C. Prospectively isolated mesenchymal stem/stromal cells
are enriched in the CD73(+) population and exhibit efficacy after
transplantation. Sci Rep. 2017;7:4838.
13. Ogawa M, Nishikawa S, Ikuta K, Yamamura F, Naito M, Takahashi K, Nishikawa S.
B cell ontogeny in murine embryo studied by a culture system with the
monolayer of a stromal cell clone, ST2: B cell progenitor develops first in the
embryonal body rather than in the yolk sac. EMBO J. 1988;7(5):1337–43.
14. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA,
Tanaka H, Omura S, Suda T. The non-osteogenic mouse pluripotent cell line,
C3H10T1/2, is induced to differentiate into osteoblastic cells by
recombinant human bone morphogenetic protein-2. Biochem Biophys Res
Commun. 1990;172(1):295–9.
15. Negishi Y, Kudo A, Obinata A, Kawashima K, Hirano H, Yanai N, Obinata M,
Endo H. Multipotency of a bone marrow stromal cell line, TBR31-2,
established from ts-SV40 T antigen gene transgenic mice. Biochem Biophys
Res Commun. 2000;268(2):450–5.
16. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V,
Yoshiki S. Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation
of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6.
Biochem Biophys Res Commun. 1996;220(2):366–71.
17. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem
cells from bone marrow (MSCs) isolated from different strains of inbred
mice vary in surface epitopes, rates of proliferation, and differentiation
potential. Blood. 2004;103(5):1662–8.
18. Abdallah BM, Ditzel N, Kassem M. Assessment of bone formation capacity
using in vivo transplantation assays: procedure and tissue analysis. Methods
Mol Biol. 2008;455:89–100.
19. Andersen RK, Zaher W, Larsen KH, Ditzel N, Drews K, Wruck W, Adjaye J,
Abdallah BM, Kassem M. Association between in vivo bone formation and
ex vivo migratory capacity of human bone marrow stromal cells. Stem Cell
Res Ther. 2015;6:196.
20. Larsen KH, Frederiksen CM, Burns JS, Abdallah BM, Kassem M. Identifying a
molecular phenotype for bone marrow stromal cells with in vivo bone
forming capacity. J Bone Miner Res. 2010;25(4):796–808.
21. Post S, Abdallah BM, Bentzon JF, Kassem M. Demonstration of the presence
of independent pre-osteoblastic and pre-adipocytic cell populations in
bone marrow-derived mesenchymal stem cells. Bone. 2008;43(1):32–9.
22. Phinney DG. Isolation of Mesenchymal Stem Cells from Murine Bone
Marrow by Immunodepletion. In: Prockop DJ, Bunnell BA, Phinney DG,
editors. Mesenchymal Stem Cells: Methods and Protocols. Totowa, NJ:
Humana Press; 2008. p. 171–86.
23. Coutu DL, Galipeau J. Roles of FGF signaling in stem cell self-renewal,
senescence and aging. Aging (Albany NY). 2011;3(10):920–33.
24. Ng F, Boucher S, Koh S, Sastry KSR, Chase L, Lakshmipathy U, Choong C,
Yang Z, Vemuri MC, Rao MS, et al. PDGF, TGF-β, and FGF signaling is
important for differentiation and growth of mesenchymal stem cells (MSCs):
transcriptional profiling can identify markers and signaling pathways
important in differentiation of MSCs into adipogenic, chondrogenic, and
osteogenic lineages. Blood. 2008;112(2):295–307.
25. Sun S, Guo Z, Xiao X, Liu B, Liu X, Tang PH, Mao N. Isolation of mouse
marrow mesenchymal progenitors by a novel and reliable method. Stem
Cells. 2003;21(5):527–35.
26. Caroti CM, Ahn H, Salazar HF, Joseph G, Sankar SB, Willett NJ, Wood LB,
Taylor WR, Lyle AN. A novel technique for accelerated culture of murine
mesenchymal stem cells that allows for sustained multipotency. Sci Rep.
2017;7:13334.
27. Coutu DL, François M, Galipeau J. Inhibition of cellular senescence by
developmentally regulated FGF receptors in mesenchymal stem cells. Blood.
2011;117(25):6801–12.
28. Fábián Z, Ramadurai S, Shaw G, Nasheuer H-P, Kolch W, Taylor C, Barry F.
Basic fibroblast growth factor modifies the hypoxic response of human
bone marrow stromal cells by ERK-mediated enhancement of HIF-1α
activity. Stem Cell Res. 2014;12(3):646–58.
29. Lisignoli G, Fini M, Giavaresi G, Nicoli Aldini N, Toneguzzi S, Facchini A.
Osteogenesis of large segmental radius defects enhanced by basic fibroblast
growth factor activated bone marrow stromal cells grown on non-woven
hyaluronic acid-based polymer scaffold. Biomaterials. 2002;23(4):1043–51.
30. Henderson B, Nair SP. Hard Labour: bacterial infection of the skeleton.
Trends Microbiol. 2003;11(12):570–7.
31. House SL, Bolte C, Zhou M, Doetschman T, Klevitsky R, Newman G, Schultz
JEJ. Cardiac-specific overexpression of fibroblast growth Factor-2 protects
against myocardial dysfunction and infarction in a murine model of low-
flow ischemia. Circulation. 2003;108(25):3140–8.
32. Meirelles LS, Nardi NB. Murine marrow-derived mesenchymal stem cell:
isolation, in vitro expansion, and characterization. Br J Haematol. 2003;
123(4):702–11.
33. Armesilla-Diaz A, Elvira G, Silva A. p53 regulates the proliferation,
differentiation and spontaneous transformation of mesenchymal stem cells.
Exp Cell Res. 2009;315(20):3598–610.
34. Li H, Fan X, Kovi RC, Jo Y, Moquin B, Konz R, Stoicov C, Kurt-Jones E,
Grossman SR, Lyle S, et al. Spontaneous expression of embryonic factors
and p53 point mutations in aged mesenchymal stem cells: a model of age-
related tumorigenesis in mice. Cancer Res. 2007;67(22):10889–98.
35. Miura M, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, Seo BM,
Sonoyama W, Zheng JJ, Baker CC, et al. Accumulated chromosomal
instability in murine bone marrow mesenchymal stem cells leads to
malignant transformation. Stem Cells. 2006;24(4):1095–103.
36. Tolar J, Nauta AJ, Osborn MJ, Mortari AP, McElmurry RT, Bell S, Xia L, Zhou
N, Riddle M, Schroeder TM, et al. Sarcoma derived from cultured
mesenchymal stem cells. Stem Cells. 2007;25(2):371–9.
37. Boregowda SV, Krishnappa V, Phinney DG. Isolation of Mouse Bone Marrow
Mesenchymal Stem Cells. In: Gnecchi M, editor. Mesenchymal Stem Cells:
Methods and Protocols. New York, NY: Springer New York; 2016. p. 205–23.
38. Eslaminejad MB, Nikmahzar A, Taghiyar L, Nadri S, Massumi M. Murine
mesenchymal stem cells isolated by low density primary culture system.
Develop Growth Differ. 2006;48(6):361–70.
39. Abdallah BM, Figeac F, Larsen KH, Ditzel N, Keshari P, Isa A, Jafari A,
Andersen TL, Delaisse J-M, Goshima Y et al: CRMP4 Inhibits Bone Formation
by Negatively Regulating BMP and RhoA Signaling. Journal of Bone and
Mineral Research 2017:n/a-n/a.
40. Abdallah BM. Marrow adipocytes inhibit the differentiation of mesenchymal
stem cells into osteoblasts via suppressing BMP-signaling. J Biomed Sci.
2017;24:11.
41. Abdallah BM, Al-Shammary A, Skagen P, Abu Dawud R, Adjaye J, Aldahmash
A, Kassem M. CD34 defines an osteoprogenitor cell population in mouse
bone marrow stromal cells. Stem Cell Res. 2015;15(3):449–58.
Abdallah et al. Biological Procedures Online            (2019) 21:3 Page 11 of 11
